Screener
Pacific Biosciences of California PACB Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Pacific Biosciences of California’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001299130-26-000122
| (In thousands) | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Deferred revenue | (423) | 808 |
| Operating lease liabilities | 2,894 | (1,730) |
| Other liabilities | 5,866 | (632) |
| Net cash used in operating activities | (80,274) | (73,433) |
| Cash flows from investing activities | ||
| Proceeds from disposal of assets | 50,000 | — |
| Payment for waiver of milestone obligation | (1,900) | — |
| Purchases of property and equipment | (4,598) | (1,939) |
Item 1. Financial Statements (unaudited):
FAQ
- What is Pacific Biosciences of California's operating cash flow?
- Pacific Biosciences of California (PACB) reported operating cash flow of -$35.58M in Q2 2026.
- How has Pacific Biosciences of California's operating cash flow changed year-over-year?
- Pacific Biosciences of California's operating cash flow decreased by 21.1% year-over-year, from -$29.38M to -$35.58M.
- What is the long-term trend for Pacific Biosciences of California's operating cash flow?
- Over 4 years (2021 to 2025), Pacific Biosciences of California's operating cash flow has grown at a 0.0% compound annual growth rate (CAGR), from -$111.18M to -$111.21M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Pacific Biosciences of California's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude